<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38826986</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Growth Differentiation Factor-15 Is Considered a Predictive Biomarker of Long COVID in Non-hospitalized Patients.</ArticleTitle><Pagination><StartPage>e59433</StartPage><MedlinePgn>e59433</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e59433</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.59433</ELocationID><Abstract><AbstractText>Mitochondrial dysfunction is associated with various diseases. Mitochondria plays a regulatory role during infection. The association between mitokines and subsequent COVID progression has not been previously studied. The retrospective cohort study aimed to investigate the potential of serum mitokines as long COVID&#xa0;biomarkers in non-hospitalized patients. Patients with confirmed SARS-CoV-2 infection and blood test reports between January 2021 and April 2023 were included. Patients were categorized into two groups, the recovered and long COVID groups, based on fatigue, decline in focus, and pain. Serum levels of growth differentiation factor 15 (GDF-15) and fibroblast growth factor-21 (FGF-21), which are affected by mitochondrial function, along with inflammatory and vascular endothelium markers, were measured using enzyme-linked immunosorbent assays (ELISA). A receiver operating characteristic curve was used to screen the biomarkers. The threshold value of GDF-15 in the acute phase was 965 pg/mL (sensitivity: 71.4%, specificity: 83.3%), indicating that GDF-15 may be associated with the presence of symptoms three months post onset. No association with inflammatory markers and vascular structures was observed. Therefore, elevated GDF-15 levels in the acute phase may act as a predictive biomarker of long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Ono et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ono</LastName><ForeName>Rie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Kampo Medicine, Tohoku University Hospital, Sendai, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Tohoku University Hospital, Sendai, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takayama</LastName><ForeName>Shin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Kampo Medicine, Tohoku University Hospital, Sendai, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, Sendai, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Michiaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arita</LastName><ForeName>Ryutaro</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Kampo Medicine, Tohoku University Hospital, Sendai, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, Sendai, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Takaaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Clinical Biology and Hormonal Regulation, Tohoku University Graduate School of Medicine, Sendai, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishii</LastName><ForeName>Tadashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Kampo and Integrative Medicine, Tohoku University Graduate School of Medicine, Sendai, JPN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">fibroblast growth factor-21</Keyword><Keyword MajorTopicYN="N">growth/differentiation factor 15</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">mitokine</Keyword><Keyword MajorTopicYN="N">non-hospitalized</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>3</Day><Hour>4</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38826986</ArticleId><ArticleId IdType="pmc">PMC11140824</ArticleId><ArticleId IdType="doi">10.7759/cureus.59433</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Long COVID terms and definitions.  [
Feb;
2024 
]. 2024. https://www.covid.gov/be-informed/longcovid/about https://www.covid.gov/be-informed/longcovid/about</Citation></Reference><Reference><Citation>True prevalence of long-COVID in a nationwide, population cohort study. Hastie CE, Lowe DJ, McAuley A, et al. Nat Commun. 2023;14:7892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10689486</ArticleId><ArticleId IdType="pubmed">38036541</ArticleId></ArticleIdList></Reference><Reference><Citation>Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Patterson BK, Guevara-Coto J, Yogendra R, et al. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. Peluso MJ, Lu S, Tang AF, et al. J Infect Dis. 2021;224:1839&#x2013;1848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome. Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodr&#xed;guez Y, Zapata E, Ram&#xed;rez-Santana C, Anaya JM. J Infect Dis. 2022;225:2155&#x2013;2162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitochondria: it is all about energy. Casanova A, Wevers A, Navarro-Ledesma S, Pruimboom L. Front Physiol. 2023;14:1114231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10167337</ArticleId><ArticleId IdType="pubmed">37179826</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitochondria as a cellular hub in infection and inflammation. Andrieux P, Chevillard C, Cunha-Neto E, Nunes JP. Int J Mol Sci. 2021;22:11338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8583510</ArticleId><ArticleId IdType="pubmed">34768767</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT. Antioxid Redox Signal. 2010;12:503&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2861545</ArticleId><ArticleId IdType="pubmed">19650712</ArticleId></ArticleIdList></Reference><Reference><Citation>Metabolism and innate immunity meet at the mitochondria. Bahat A, MacVicar T, Langer T. Front Cell Dev Biol. 2021;9:720490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8353256</ArticleId><ArticleId IdType="pubmed">34386501</ArticleId></ArticleIdList></Reference><Reference><Citation>MAVS is energized by Mff which senses mitochondrial metabolism via AMPK for acute antiviral immunity. Hanada Y, Ishihara N, Wang L, et al. Nat Commun. 2020;11:5711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7658986</ArticleId><ArticleId IdType="pubmed">33177519</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitochondrial metabolism regulates macrophage biology. Wang Y, Li N, Zhang X, Horng T. J Biol Chem. 2021;297:100904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8294576</ArticleId><ArticleId IdType="pubmed">34157289</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitochondria, immunosenescence and inflammaging: a role for mitokines? Conte M, Martucci M, Chiariello A, Franceschi C, Salvioli S. Semin Immunopathol. 2020;42:607&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7666292</ArticleId><ArticleId IdType="pubmed">32757036</ArticleId></ArticleIdList></Reference><Reference><Citation>Comprehensive profiling of inflammatory factors revealed that growth differentiation factor-15 is an indicator of disease severity in COVID-19 patients. Teng X, Zhang J, Shi Y, et al. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320433</ArticleId><ArticleId IdType="pubmed">34335566</ArticleId></ArticleIdList></Reference><Reference><Citation>Response to glucocorticoid therapy in patients with mild to moderate coronavirus disease 2019 at a Japanese care facility. Kikuchi A, Arita R, Ono R, et al. Tohoku J Exp Med. 2022;257:97&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">35387909</ArticleId></ArticleIdList></Reference><Reference><Citation>Coping with stress: the mitokine GDF-15 as a biomarker of COVID-19 severity. Ahmed DS, Isnard S, Berini C, Lin J, Routy JP, Royston L. Front Immunol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8888851</ArticleId><ArticleId IdType="pubmed">35251002</ArticleId></ArticleIdList></Reference><Reference><Citation>GDF15 and growth control. Emmerson PJ, Duffin KL, Chintharlapalli S, Wu X. Front Physiol. 2018;9:1712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277789</ArticleId><ArticleId IdType="pubmed">30542297</ArticleId></ArticleIdList></Reference><Reference><Citation>A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15. Patsalos A, Halasz L, Medina-Serpas MA, et al. J Exp Med. 2022;219:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8635277</ArticleId><ArticleId IdType="pubmed">34846534</ArticleId></ArticleIdList></Reference><Reference><Citation>Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. Chung HK, Ryu D, Kim KS, et al. J Cell Biol. 2017;216:149&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5223607</ArticleId><ArticleId IdType="pubmed">27986797</ArticleId></ArticleIdList></Reference><Reference><Citation>FGF21 as modulator of metabolism in health and disease. Tezze C, Romanello V, Sandri M. Front Physiol. 2019;10:419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6478891</ArticleId><ArticleId IdType="pubmed">31057418</ArticleId></ArticleIdList></Reference><Reference><Citation>Possible pathogenesis and prevention of long COVID: SARS-CoV-2-induced mitochondrial disorder. Chen TH, Chang CJ, Hung PH. Int J Mol Sci. 2023;24:8034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10179190</ArticleId><ArticleId IdType="pubmed">37175745</ArticleId></ArticleIdList></Reference><Reference><Citation>ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Komaroff AL, Lipkin WI. Front Med (Lausanne) 2023;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Morris G, Maes M. Metab Brain Dis. 2014;29:19&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">24557875</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Cunnane SC, Trushina E, Morland C, et al. Nat Rev Drug Discov. 2020;19:609&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948516</ArticleId><ArticleId IdType="pubmed">32709961</ArticleId></ArticleIdList></Reference><Reference><Citation>Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Boland B, Yu WH, Corti O, et al. Nat Rev Drug Discov. 2018;17:660&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456907</ArticleId><ArticleId IdType="pubmed">30116051</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitochondria at the interface between neurodegeneration and neuroinflammation. Bader V, Winklhofer KF. Semin Cell Dev Biol. 2020;99:163&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">31154011</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis. Melo AK, Milby KM, Caparroz AL, et al. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8241122</ArticleId><ArticleId IdType="pubmed">34185801</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomarkers in long COVID-19: a systematic review. Lai YJ, Liu SH, Manachevakul S, Lee TA, Kuo CT, Bello D. Front Med (Lausanne) 2023;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and the vasculature: current aspects and long-term consequences. Mart&#xed;nez-Salazar B, Holwerda M, St&#xfc;dle C, et al. Front Cell Dev Biol. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8887620</ArticleId><ArticleId IdType="pubmed">35242762</ArticleId></ArticleIdList></Reference><Reference><Citation>Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Petersen EL, Go&#xdf;ling A, Adam G, et al. Eur Heart J. 2022;43:1124&#x2013;1137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>